Ginkgo Bioworks Holdings Inc. (DNA)
NYSE · Healthcare
Ginkgo Bioworks Holdings Inc. Shareholder Equity 2019–2025
Ginkgo Bioworks Holdings Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Ginkgo Bioworks Holdings Inc. shareholder equity as of December 31, 2025: 508.6M, a 28.97% decrease year-over-year.
- Ginkgo Bioworks Holdings Inc. shareholder equity for 2025 were 508.6M, a 28.97% decrease from 2024.
- Ginkgo Bioworks Holdings Inc. shareholder equity for 2024 were 716.1M, a 34.73% decrease from 2023.
- Ginkgo Bioworks Holdings Inc. shareholder equity for 2023 were 1.10B, a 36.81% decrease from 2022.
- Ginkgo Bioworks Holdings Inc. shareholder equity for 2022 were 1.74B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ginkgo Bioworks Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $509 |
| 2024 | $716 |
| 2023 | $1,097 |
| 2022 | $1,736 |
| 2021 | $1,505 |
| 2020 | $461 |
Ginkgo Bioworks Holdings Inc. Shareholder Equity — FAQ
Ginkgo Bioworks Holdings Inc. (DNA) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNA's shareholder equity history?
The chart and table above show Ginkgo Bioworks Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.